SALVARESE, NICOLA
 Distribuzione geografica
Continente #
NA - Nord America 2.635
EU - Europa 348
AS - Asia 278
AF - Africa 2
OC - Oceania 1
SA - Sud America 1
Totale 3.265
Nazione #
US - Stati Uniti d'America 2.634
CN - Cina 210
IT - Italia 125
FI - Finlandia 74
VN - Vietnam 54
SE - Svezia 49
DE - Germania 40
FR - Francia 19
GB - Regno Unito 16
UA - Ucraina 13
IN - India 11
IE - Irlanda 5
NL - Olanda 4
AT - Austria 2
NG - Nigeria 2
AU - Australia 1
CA - Canada 1
CL - Cile 1
DK - Danimarca 1
MY - Malesia 1
PK - Pakistan 1
TR - Turchia 1
Totale 3.265
Città #
Fairfield 385
Chandler 343
Houston 263
Ann Arbor 245
Woodbridge 219
Ashburn 151
Seattle 147
Wilmington 140
Cambridge 129
Jacksonville 57
Princeton 56
Dong Ket 53
Medford 48
Beijing 46
Des Moines 45
Nanjing 42
Padova 42
San Diego 39
Boardman 33
Helsinki 33
Roxbury 21
Los Angeles 11
Shenyang 11
Columbus 10
New York 10
Changsha 9
Nanchang 9
Pune 8
Ferrara 7
Cagliari 6
Guangzhou 6
Hefei 6
Jinan 6
Kunming 6
Milan 6
Trieste 6
Dublin 5
Hebei 5
Jiaxing 5
London 5
Fuzhou 4
Norwalk 4
Ogden 3
Shanghai 3
Tianjin 3
Amsterdam 2
Genoa 2
Ibadan 2
Kharkiv 2
Kilburn 2
Kreischa 2
Montegrotto Terme 2
Mottola 2
Rockville 2
San Francisco 2
Sant'agostino 2
Stienta 2
Taizhou 2
Verona 2
Vienna 2
Aarhus 1
Catania 1
Changchun 1
Chiswick 1
Chongqing 1
Cittadella 1
Dearborn 1
Esslingen am Neckar 1
Falkenstein 1
Frankfurt am Main 1
Hangzhou 1
Harbin 1
Ho Chi Minh City 1
Huzhou 1
Islington 1
Kuala Lumpur 1
Lappeenranta 1
Las Vegas 1
Mcallen 1
Messina 1
Napoli 1
Paris 1
Pozzo 1
San Giovanni In Persiceto 1
Selvazzano Dentro 1
Tappahannock 1
Toronto 1
Wuhan 1
Yenibosna 1
Zhengzhou 1
Totale 2.751
Nome #
[99mTc][Tc(N)(DASD)(PNPn)]+ (DASD=1,4-dioxa-8-azaspiro[4,5]decandithiocarbamate, PNPn=bisphosphinoamine) for myocardial imaging: synthesis, pharmacological and pharmacokinetic studies 117
99mTc(N)-DBODC(5), a potential radiolabeled probe for SPECT of multidrug resistance: in vitro study 115
Synthesis, characterization and biological evaluation of [188Re(N)(cys-)(PNP)]+/0 mixed-ligand complexes as prototypes for the development of 188Re(N)-based target-specific radiopharmaceuticals 109
[99mTc(N)PNP]-scaffold for SPECT of multidrug resistance: Early in-vitro study 108
Folic Acid-Conjugated Europium Complexes as Luminescent Probes for Selective Targeting of Cancer Cells 102
Novel [99mTcIII(PS)2(Ln)] Mixed-Ligand Compounds (PS = Phosphino-thiolate; L = Dithiocarbamate) Useful in Design and Development of TcIII-Based Agents: Synthesis, in Vitro, and ex Vivo Biodistribution Studies 99
[99mTc][Tc(N)PNP43]-Labeled RGD Peptides As New Probes for a Selective Detection of αvβ3 Integrin: Synthesis, Structure-Activity and Pharmacokinetic Studies 96
Synthesis and Characterization of [MIII(PS)2(L)] Mixed-Ligand Compounds (M = Re,99Tc; PS = Phosphinothiolate; L = Dithiocarbamate) as Potential Models for the Development of New Agents for SPECT Imaging and Radiotherapy 92
TcIII-based mixed complexes for the design and the development of new SPECT tracers 91
A bis(thiosemicarbazone) bifunctional chelating agent for nitrido-technetium-99m and copper-64 based radiopharmaceuticals 90
Tc-99m(N)-DBODC(5) from cardiology to oncology: preliminary in vitro study 88
Studies of new [Tc(N)(PS)]-based mixed compounds as analogues of WAY 100635 85
Melanoma targeting with [99mTc(N)(PNP3)]-labeled α-melanocyte stimulating hormone peptide analogs: Effects of cyclization on the radiopharmaceutical properties 85
99mTc(N)-DBODC(5) from cardiology to oncology: preliminary in vitro study 84
New 99mTc-radioimmunoconjugates for pancreatic carcinoma detection 82
Assessment of the best N3− donors in preparation of [M(N)(PNP)]-based (M=99mTc-; 188Re) target-specific radiopharmaceuticals: Comparison among succinic dihydrazide (SDH), N-methyl-S-methyl dithiocarbazate (HDTCZ) and PEGylated N-methyl-S-methyl dithiocarbazate (HO2C-PEG600-DTCZ) 79
64Cu-dithiocarbamate compounds for theragnostic applications: Preliminary in-vitro studies 77
[99mTc(N)(DBODC)(5)]+: sub-cellular distribution and metabolism studies of this new potential myocardial imaging agent 76
Transglutaminase-mediated conjugation and nitride-technetium-99m labelling of a bis(thiosemicarbazone) bifunctional chelator 76
Synthesis and characterization of rhenium(III) complexes with (Ph2PCH2CH2)2NR diphosphinoamine ligands 74
New [99mTc(N)(DTC)(PNP)]+ complexes as potential myocardial imaging agents 71
Chelating Systems for 99mTc/188Re in the Development of Radiolabeled Peptide Pharmaceuticals 69
[Re-188(N)(cys similar to)(PNP)](+/0) mixed ligand compounds as models for target specific agents 65
Synthesis and biological evaluation of new [Tc(N)(PS)]-based mixed-ligand compounds useful in the design of target-specific radiopharmaceuticals: the 2-methoxyphenylpiperazine dithiocarbamate derivatives as an example 64
A bis(thiosemicarbazone) bifunctional chelating agent for Nitrido-Technetium-99m and Copper-64 based radiopharmaceuticals 64
Synthesis and Characterization of Novel Hexacoordinated, Asymmetrical M(III) (M = Re, 99gTc) Complexes as Models for the Development of Potential Tracers for SPECT Imaging and Radiotherapy 60
Development of 177Lu-scFvD2B as a Potential Immunotheranostic Agent for Tumors Overexpressing the Prostate Specific Membrane Antigen 60
Reactivity of the [M(PS)2]+Building Block (M = ReIIIand99mTcIII; PS = Phosphinothiolate) toward Isopropylxanthate and Pyridine-2-thiolate 59
[99mTc(N)(DBODC)(5)]+: sub-cellular distribution and metabolism studies of this new potential myocardial imaging agent 58
Reactions of the tridentate and tetradentate amine ligands di-(2-picolyl)(N-ethyl)amine and 2,5-bis-(2-pyridylmethyl)-2,5 diazohexane with technetium nitrosyl complexes 57
64Cu-Labelled compounds with dithiocarbamate ligands for theragnostic applications: preliminary in vitro studies 54
Biological in vitro and in vivo studies of a series of new asymmetrical cationic [99mTc(N)(DTC-Ln)(PNP)]+ complex (DTC-Ln = alicyclic dithiocarbamate, PNP = diphosphinoamine) 54
99mTc(N)(DASD)(pnpn)]+ (DASD=1,4-dioxa-8-azaspiro[4,5]decandithiocarba pnpn=bisphosphinoamine) for myocardial imaging 53
Synthesis and biological evaluation of new [Tc(N)(R2PS)]-based mixed compounds as analogues of WAY 100635 52
Synthesis and biological evaluation of new [Tc-99m(III)( PS)(2)(L)] mixed-ligand compounds (PS= phosphino-thiolate; L=dithiocarbamate), useful in design and development of Tc(III)radiopharmaceuticals 45
Preliminary studies on the transglutaminase-mediated derivatizations of Apomyoglobin (apoMb) with H2ATSM-6ACA 44
Cu-64-labelled compounds with dithiocarbamate ligands for theragnostic applications: preliminary in vitro studies 43
Synthesis and biological evaluation of Technetium(III)-based radiopharmaceuticals 42
Site-specific derivatization of apomyoglobin with H2BTS-6ACA mediated by transglutaminase 41
Synthesis and biological evaluation of new [99mTc(N)(PNPn)]2+-labeled cRGDfK peptide: preliminary studies 39
Synthesis and characterization of novel asymmetrical M(III) (M = Re, 99gTc) complexes as models for the development of potential tracers for SPECT imaging and radiotherapy 38
Site-specific protein conjugation with the [185/187Re(N)(PNP)]-scaffold via Transglutaminase 35
99mTc(N)-DBODC(5), a potential probe for SPECT imaging of multidrug resistance: in vitro study 35
Site-specific derivatization of proteins using metal ion chelating peptides and transglutaminase 34
Synthesis, in vitro and in vivo evaluation of new 99mTc-labeled cyclic RGDfK peptide monocationic complexes 31
[99mTc(N)(DASD)(PNPn)]+ Compounds as Myocardial Perfusion Imaging Agents. 29
[Tc-99m(N)PNP]-moiety: a suitable scaffold for the developmant of radiolabeled probes for SPECT of multidrug resistance. In vitro study 28
Synthesis and Characterization of Novel Asymmetrical M(III) (M = Re, 99gTc) Complexes as Models for the Development of Potential Tracers for SPECT Imaging and Radiotherapy 25
Method for labeling of sensitive and thermosensitive targeting biomolecules with technetium based compounds 25
The [Tc(N)PNP] Metal Fragment Labeled Peptide for MC1 Receptors Imaging: preliminary studies 24
Synthesis and biological evaluation of new [99mTc(N)(PNPn)]2+-labeled cRGDfK peptide: preliminary studies 23
Impact of Different [Tc(N)PNP]-Scaffolds on the Biological Properties of the Small cRGDfK Peptide: Synthesis, In Vitro and In Vivo Evaluations 19
Development of a new prostate cancer theranostic radiopharmaceutical 19
Impact of Different [99mtc][Tc(N)PNP]-Scaffolds on the Labeling of the Rgdfk Peptide and the Biological Properties of the Obtained Radiocompounds 4
Totale 3.288
Categoria #
all - tutte 11.733
article - articoli 8.670
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 179
patent - brevetti 79
selected - selezionate 0
volume - volumi 0
Totale 20.661


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019223 0 0 0 0 0 0 0 0 0 56 97 70
2019/2020699 109 21 20 59 72 48 89 94 70 63 38 16
2020/2021423 25 21 21 28 7 20 1 45 45 60 47 103
2021/2022520 16 77 69 23 25 31 23 44 18 14 49 131
2022/2023619 104 77 11 93 116 76 4 30 58 11 31 8
2023/2024291 26 55 49 26 34 26 33 20 6 16 0 0
Totale 3.288